[The influence of tolbutamide on diabetic fatty liver].
D000368:Aged; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005234:Fatty Liver / Q000188:drug therapy*; D005260:Female; D006003:Glycogen / Q000032:analysis; D006801:Humans; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D010919:Placebos; D014044:Tolbutamide / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010743:Phospholipids; D010919:Placebos; D014280:Triglycerides; D006003:Glycogen; D002784:Cholesterol; D014044:Tolbutamide
Der Einfluss von Tolbutamid auf die diabetische Fettleber.